Sandler Capital Management Charles River Laboratories International, Inc. Transaction History

Sandler Capital Management

$870 Million
Q4 2024

A detailed history of Sandler Capital Management transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Sandler Capital Management holds 57,718 shares of CRL stock, worth $9.64 Million. This represents 1.22% of its overall portfolio holdings.

Number of Shares

57,718

Previous 4,790 1104.97%

Holding current value

$9.64 Million

Previous $943,000 1029.8%

% of portfolio

1.22%

Previous 0.14%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$178.58 - $220.69 $9.45 Million - $11.7 Million	52,928 Added 1104.97%	57,718 $10.7 Million
Q3 2024 Nov 14, 2024	SELL	$187.96 - $245.29 $3.41 Million - $4.45 Million	-18,131 Reduced 79.1%	4,790 $943,000
Q2 2024 Aug 14, 2024	SELL	$206.39 - $268.73 $7.31 Million - $9.52 Million	-35,410 Reduced 60.71%	22,921 $4.74 Million
Q1 2024 May 15, 2024	BUY	$203.52 - $273.43 $5.46 Million - $7.34 Million	26,831 Added 85.18%	58,331 $15.8 Million
Q4 2023 Feb 14, 2024	SELL	$164.52 - $238.84 $6.44 Million - $9.35 Million	-39,157 Reduced 55.42%	31,500 $7.45 Million
Q2 2023 Aug 14, 2023	BUY	$183.71 - $210.25 $7.98 Million - $9.13 Million	43,420 Added 159.42%	70,657 $14.9 Million
Q1 2023 May 15, 2023	SELL	$191.89 - $259.92 $18.1 Million - $24.5 Million	-94,163 Reduced 77.56%	27,237 $5.5 Million
Q4 2022 Feb 14, 2023	BUY	$197.11 - $250.07 $23.9 Million - $30.4 Million	121,400 New	121,400 $26.4 Million
Q2 2022 Aug 15, 2022	SELL	$204.13 - $302.4 $12 Million - $17.8 Million	-58,835 Reduced 71.39%	23,575 $5.04 Million
Q1 2022 May 16, 2022	BUY	$255.51 - $362.11 $14.9 Million - $21.1 Million	58,227 Added 240.78%	82,410 $23.4 Million
Q4 2021 Feb 14, 2022	SELL	$351.38 - $448.68 $33.6 Million - $42.9 Million	-95,504 Reduced 79.79%	24,183 $9.11 Million
Q3 2021 Nov 15, 2021	SELL	$372.64 - $458.3 $21.5 Million - $26.4 Million	-57,680 Reduced 32.52%	119,687 $49.4 Million
Q2 2021 Aug 16, 2021	SELL	$294.17 - $371.65 $6.16 Million - $7.79 Million	-20,954 Reduced 10.57%	177,367 $65.6 Million
Q1 2021 May 17, 2021	BUY	$249.67 - $299.48 $2.57 Million - $3.08 Million	10,280 Added 5.47%	198,321 $57.5 Million
Q4 2020 Feb 16, 2021	BUY	$222.0 - $252.62 $3.04 Million - $3.46 Million	13,700 Added 7.86%	188,041 $47 Million
Q3 2020 Nov 16, 2020	SELL	$175.56 - $226.45 $8.77 Million - $11.3 Million	-49,941 Reduced 22.27%	174,341 $39.5 Million
Q2 2020 Aug 14, 2020	BUY	$118.84 - $189.72 $5.11 Million - $8.15 Million	42,982 Added 23.71%	224,282 $39.1 Million
Q1 2020 May 15, 2020	BUY	$98.9 - $178.34 $17.9 Million - $32.3 Million	181,300 New	181,300 $22.9 Million

Others Institutions Holding CRL

# of Institutions

709

Shares Held

49.8M

Call Options Held

122K

Put Options Held

239K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.49B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sandler Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Sandler Capital Management with notifications on news.

Account

Sandler Capital Management Charles River Laboratories International, Inc. Transaction History